Pulmonary vascular disease & thromboembolism

Long-Term Outcomes Following Catheter-Based Therapies in Older Adults With Acute Pulmonary Embolism

JACC AdvPublished Retrospective cohort study

Authors' conclusion

Among older adults with high-risk or intermediate-risk PE, patients treated with CBT experienced lower mortality over the follow-up of up to 3 years, but higher risk of in-hospital bleeding complications.

Study context

Population
Medicare fee-for-service beneficiaries aged 65 to 99 years admitted for high- or intermediate-risk pulmonary embolism (PE), 2017 to 20206,742 high-risk
Exposure
CBT vs no CBT
Outcome
Long-term mortality
Follow-up
Up to 3 years
Methodological detailspropensity score matching weight, instrumental variable analysis
  • Propensity score matching weight
  • Instrumental variable analysis

Main finding

As reported in the abstract

3-year mortality

CBT

High-risk PE
45.7%
Intermediate-risk PE
14.9%

No CBT

High-risk PE
65.5%
Intermediate-risk PE
30.3%

High-risk PE

CBT45.7%
No CBT65.5%

Intermediate-risk PE

CBT14.9%
No CBT30.3%
CBT vs No CBTAdjusted hazard ratio (95% CI)
High-risk PE
0.76(0.67–0.85)
Intermediate-risk PE
0.69(0.63–0.75)

Observational data: associations, not effects.

Further findings

OutcomeCBTNo CBTaOR (95% CI)
In-hospital deathHigh-risk PE0.73 (0.61–0.87)
High-risk PE29.0%43.9%
Intermediate-risk PE3.1%4.1%
In-hospital deathIntermediate-risk PE; no evidence of difference0.93 (0.75–1.16)

Safety

OutcomeCBTNo CBTaOR (95% CI)
Intracranial hemorrhageHigh-risk PE2.29 (1.18–4.44)
High-risk PE2.1%1.0%
Intermediate-risk PE0.5%0.3%
Intracranial hemorrhageIntermediate-risk PE2.04 (1.17–3.55)

Original publication

Long-Term Outcomes Following Catheter-Based Therapies in Older Adults With Acute Pulmonary Embolism. JACC Adv. Published 28 May 2025. doi:10.1016/j.jacadv.2025.101770

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.